MentalHealthDaily

Analyzing Brain Connectivity with Advanced Neuroimaging to Treat Major Depression (2023 Research)

by GLOOM

Depression, a leading cause of disability globally, presents a myriad of treatment challenges. Recent advancements in neuroimaging, particularly in understanding brain connectivity, offer a new lens through which we can view and potentially enhance the treatment of Major Depressive Disorder (MDD). Highlights: Major Depressive Disorder (MDD) affects millions worldwide, with traditional treatments showing varied success …

Gray Matter Abnormalities in Major Depression & Social Anxiety (2023 Analysis)

by GLOOM

Major depressive disorder (MDD) and social anxiety disorder (SAD) are two of the most prevalent mental health issues facing society today. They often occur together, challenging both patients and healthcare providers. Recent neuroimaging studies have begun to shed light on the unique and overlapping characteristics of these disorders, offering new insights into their complex neurobiology. …

Facebook Addiction: Brain Scans Compared to Drug Addicts

by GLOOM

As of 2013, there were over 500 million people using Facebook and roughly half of all users log-in to the social media platform on a daily basis. It is clearly the most popular social media platform compared to others like Twitter and LinkedIn. The average person on Facebook has over 100 friends and spends over …

How To Improve Psychiatric Treatment Outcomes with Technology & Variable Tracking

by GLOOM

It’s blatantly obvious that psychiatry is an imperfect practice. These days people often seek the help of a psychiatrist with the belief that a pill can be prescribed to essentially cure a disease or get symptoms of a mental illness under control. While psychiatry can offer many benefits in the treatment of certain conditions, especially …